ESSA Pharma

EPIX NASDAQ
2.790
-0.110
-3.80%
休市 16:00 07/19 EDT
开盘
2.900
昨收
2.900
最高
2.900
最低
2.790
成交量
690
成交均量(3M)
6,569
52周最高
4.500
52周最低
1.870
换手率
0.01%
市值
2,221.77万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供ESSA Pharma EPIX股票价格,ESSA Pharma股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

ESSA Pharma Inc. is a Canada-based clinical-stage development pharmaceutical company. The Company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer (CRPC). The Company is developing drugs, which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR). The Company's product candidate, EPI-506 is a selective, oral small molecule pro-drug that blocks the N-terminal domain of the AR. EPI-506 is a pro-drug of EPI-002, a stereoisomer of the Company's discovery compound, EPI-001. The Company is conducting a Phase I/II clinical study to determine the safety, tolerability, maximum tolerated dose, pharmacokinetics and efficacy of EPI-506 in patients with metastatic CRPC. It is focused on developing EPI-506 as its clinical-development product candidate. ESSA Pharmaceuticals Corp. is the Company's subsidiary. The Company has not generated any revenues.
展开 >

最近浏览

名称
价格
涨跌幅